Skip to main content
Premium Trial:

Request an Annual Quote

Fluidic Analytics: Joe Keegan

Fluidic Analytics has appointed Joe Keegan as the firm's chairman. Keegan currently serves on the boards of Bio-Techne and Interpace Diagnostics, as well as a number of early- and growth-stage companies in the life sciences tools and diagnostic industries. Prior to Fluidic Analytics, Keegan served as CEO as ForteBio until it was sold to Pall Corporation. Before ForteBio, Keegan was CEO of Molecular Devices. Keegan has also held the role of chairman of the Analytical Life Science & Diagnostics Association, non-executive chairman of Labcyte, and non-executive director of Advanced Cellular Diagnostics, ProteinSimple, and Seahorse Bioscience.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.